Literature DB >> 20620001

Restenosis after carotid endarterectomy in a multicenter regional registry.

Philip P Goodney1, Brian W Nolan, Jens Eldrup-Jorgensen, Donald S Likosky, Jack L Cronenwett.   

Abstract

BACKGROUND: Level I evidence shows conventional carotid endarterectomy (CEA) with patch angioplasty results in lower rates of restenosis. However, whether this information has affected practice patterns and outcomes in real-world vascular surgery settings is unclear.
METHODS: Within the Vascular Study Group of New England (VSGNE), we studied 2981 patients undergoing 2981 first-time CEAs between January 1, 2003, and June 31, 2008. Rates of restenosis (defined by duplex ultrasound imaging at the 1-year follow-up) were estimated using life-table analysis. Cox proportional hazards models were used to identify multivariable predictors of postoperative restenosis ≤ 1 year.
RESULTS: Across 58 surgeons and 11 hospitals, we studied 2611 conventional CEAs (88% of all CEAs) and 370 eversion CEAs (12% of all CEAs). Median follow-up was 12.8 months (range, 1-35 months). The proportion of conventional CEAs performed with patching increased from 87% to 96% (P < .001) between 2003 and 2008, whereas eversion CEA declined from 18% to 5% (P < .001). Restenosis occurred in 303 patients (10%); by life-table analysis, the restenosis rate at 1 year was 6.2% (95% confidence interval [CI], 4.7%-6.8%). Restenoses were most commonly noncritical: 50%-79% restenosis in 7.9%, 80%-99% restenosis in 1.7%, and occlusion in 0.5%. Univariate analyses showed significant differences in 80% to 100% restenosis by procedure type (2% in conventional CEA, 6% in eversion CEA, P < .002), the year of procedure (3.2% in 2003, 0% in 2008; P < .03), and use of patching in conventional CEA (2.9% no patch, 1% with patch; P < .008). By multivariable analysis, absence of patching (hazard ratio [HR], 3.2; 95% CI, 1.5-7.0), contralateral internal carotid artery stenosis > 80% (HR, 4.1; 95% CI, 1.4-11.5), and dialysis dependence (HR, 3.5; 95% CI, 1.2-9.8) were independently associated with a higher risk of an 80% to 100% restenosis. Of the 51 patients with 80% to 99% restenosis, 14 underwent reintervention ≤ 1 year, comprising 4 reoperations and 10 carotid artery stent procedures. Of the 15 patients with a carotid occlusion ≤ 1 year, transient ischemic attacks occurred in 2 and a disabling stroke in 1.
CONCLUSIONS: In our region, restenosis after CEA, especially clinically significant restenosis ≤ 1 year after surgery, decreased slightly over time. This improvement in outcome was associated with several factors, including an increase in patching after conventional CEA, a process of care that was studied and encouraged within our vascular study group. These results highlight the utility of regional quality-improvement efforts in improving outcomes in vascular surgery.
Copyright © 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20620001     DOI: 10.1016/j.jvs.2010.05.005

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  19 in total

1.  Long-term Comparative Outcomes of Carotid Artery Stenting Following Previous Carotid Endarterectomy vs De Novo Lesions.

Authors:  Albeir Y Mousa; Ali F AbuRahma; Joseph Bozzay; Mike Broce; Maher Kali; Michael Yacoub; Patrick Stone; Mark C Bates
Journal:  J Endovasc Ther       Date:  2015-04-15       Impact factor: 3.487

Review 2.  Roles for specialty societies and vascular surgeons in accountable care organizations.

Authors:  Philip P Goodney; Elliott S Fisher; Richard P Cambria
Journal:  J Vasc Surg       Date:  2012-03       Impact factor: 4.268

3.  Shared quality data are associated with increased protamine use and reduced bleeding complications after carotid endarterectomy in the Vascular Study Group of New England.

Authors:  Reshma B Patel; Peter Beaulieu; Karen Homa; Philip P Goodney; Andrew C Stanley; Jack L Cronenwett; David H Stone; Daniel J Bertges
Journal:  J Vasc Surg       Date:  2013-09-05       Impact factor: 4.268

4.  Association of Quality Improvement Registry Participation With Appropriate Follow-up After Vascular Procedures.

Authors:  Benjamin S. Brooke; Adam W. Beck; Larry W. Kraiss; Andrew W. Hoel; Andrea M. Austin; Amir A. Ghaffarian; Jack L. Cronenwett; Philip P. Goodney
Journal:  JAMA Surg       Date:  2018-03-01       Impact factor: 14.766

5.  Risks Associated With Primary and Redo Carotid Endarterectomy in the Endovascular Era.

Authors:  Isibor J. Arhuidese; Muhammad Faateh; Besma J. Nejim; Satinderjit Locham; Christopher J. Abularrage; Mahmoud B. Malas
Journal:  JAMA Surg       Date:  2018-03-01       Impact factor: 14.766

6.  A comparison of results with eversion versus conventional carotid endarterectomy from the Vascular Quality Initiative and the Mid-America Vascular Study Group.

Authors:  Joseph R Schneider; Irene B Helenowski; Cheryl R Jackson; Michael J Verta; Kimberly C Zamor; Nilesh H Patel; Stanley Kim; Andrew W Hoel
Journal:  J Vasc Surg       Date:  2015-05       Impact factor: 4.268

7.  Completion imaging after carotid endarterectomy in the Vascular Study Group of New England.

Authors:  Jessica B Wallaert; Philip P Goodney; John J Vignati; David H Stone; Brian W Nolan; Daniel J Bertges; Daniel B Walsh; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2011-03-31       Impact factor: 4.268

8.  A regional quality improvement effort to increase beta blocker administration before vascular surgery.

Authors:  Philip P Goodney; Jens Eldrup-Jorgensen; Brian W Nolan; Daniel J Bertges; Donald S Likosky; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2011-02-21       Impact factor: 4.268

9.  Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative.

Authors:  Peter A Soden; Sara L Zettervall; Thomas Curran; Ageliki G Vouyouka; Philip P Goodney; Joseph L Mills; John W Hallett; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-09-28       Impact factor: 4.268

10.  Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery.

Authors:  Randall R De Martino; Jens Eldrup-Jorgensen; Brian W Nolan; David H Stone; Julie Adams; Daniel J Bertges; Jack L Cronenwett; Philip P Goodney
Journal:  J Vasc Surg       Date:  2014-01-16       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.